Search for medicines for human use
Index of medicine substances
Casirivimab + imdevimab • Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies (J06BD07)
Caspofungin • Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use (J02AX04)
Catumaxomab • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX03)
Cefaclor • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins (J01DC04)
Cefadroxil • Antiinfectives for systemic use | Other beta-lactam antibacterials | First-generation cephalosporins (J01DB05)
Cefamandole • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins (J01DC03)
Cefazolin • Antiinfectives for systemic use | Other beta-lactam antibacterials | First-generation cephalosporins (J01DB04)
Cefepime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Fourth-generation cephalosporins (J01DE01)
Cefiderocol • Antiinfectives for systemic use | Other beta-lactam antibacterials | Other cephalosporins and penems (J01DI04)
Cefixime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD08)
Cefonicide • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins (J01DC06)
Cefoperazone • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD12)
Cefoperazone + sulbactam • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD62)
Cefotaxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD01)
Cefpirom • Antiinfectives for systemic use | Other beta-lactam antibacterials | Fourth-generation cephalosporins (J01DE02)
Cefpodoxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD13)
Cefprozil • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins (J01DC10)
Ceftaroline fosmil • Antiinfectives for systemic use | Other beta-lactam antibacterials | Other cephalosporins and penems (J01DI02)
Ceftazidime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD02)
Ceftazidime + avibactam • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD52)
Ceftibuten • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD14)
Ceftolozan + tazobactam • Antiinfectives for systemic use | Other beta-lactam antibacterials | Other cephalosporins and penems (J01DI54)
Ceftriaxone • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins (J01DD04)
Cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins (J01DC02)
Celecoxib • Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs (M01AH01)
Celiprolol • Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB08)
Cellular inactivated typhoid vaccine • Antiinfectives for systemic use | Bacterial vaccines | Typhoid vaccines (J07AP02)
Cemiplimab • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF06)
Cenobamate • Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX25)
Cephalexin • Antiinfectives for systemic use | Other beta-lactam antibacterials | First-generation cephalosporins (J01DB01)